Efficacy and safety assessment of the use of bicalutamide* with anastrozole* for the treatment of gonadotrophin-independent precocious puberty in boys with testotoxicosis CLOSED TO RECRUITMENT
| Type of clinical trial
|
Drug clinical trial |
| Recruiting project
|
No
|
| Orpha number
|
ORPHA59473 |
| Status
|
Terminated trial |
|
| Geographic coverage
|
National |
| Funding body(ies)
|
- |
| Sponsor
|
Astrazeneca pharmaceuticals |
|
Principal investigator of clinical trial :
Sandie O'BRIEN
AstraZeneca Pharmaceuticals
Alderley Park, Macclesfield
CHESHIRE SK10 4TF
UNITED KINGDOM
More information
|
Phone
: 44 (0)1625 517 772
Fax
: 44 (0)1625 512 911
Website
|
The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.
